The Department of Defense last week issued a new directive (pdf) that regulates the conduct of its intelligence activities. It replaces a prior directive from 1988, and reflects the structural changes in national and military intelligence that have occurred since then.
“All DoD intelligence and CI [counterintelligence] activities shall be carried out pursuant to the authorities and restrictions of the U.S. Constitution, applicable law, [Executive Order 12333], the policies and procedures authorized herein, and other relevant DoD policies…,” the new directive reaffirms.
“Special emphasis shall be given to the protection of the constitutional rights and privacy of U.S. persons.”
“No Defense Intelligence or CI Component shall request any person or entity to undertake unauthorized activities on behalf of the Defense Intelligence or CI Component.”
“Under no circumstances shall any DoD Component or DoD employee engage in, or conspire to engage in, assassination.”
See “DoD Intelligence Activities,” Department of Defense Directive 5240.01, August 27, 2007.
The new directive renews the authorization of a 1982 DoD Regulation on “Procedures Governing the Activities of DoD Intelligence Components that Affect United States Persons” (pdf), DoD 5240.1-R, December 11, 1982.
Internal disagreements present a growing concern about FDA leadership overruling the expert opinions of scientific staff and proceeding with official approvals, thus undermining staff expertise, decreasing agency morale, and potentially diminishing public trust.
Public meetings led by FDA Advisory Committees are instrumental in facilitating transparent deliberation between the FDA, the advisory body, and the American public.
FAS estimates that India has produced enough weapons-grade plutonium for up to 210 nuclear warheads, but has likely assembled closer to 172.
We are excited to engage in a productive and collaborative partnership with IAM, with the goal of fostering a positive and mutually beneficial working environment for all FAS employees.